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Medication errors in outpatient care in Colombia, 2005-2013
Jorge E. Machado-Alba, Juan Carlos Moncada, Paula Andrea Moreno-Gutiérrez
Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia,
Universidad Tecnológica de Pereira-Audifarma, S. A., Pereira, Colombia
Introduction: Medication errors outside the hospital have been poorly studied despite representing an 
important threat to patient safety.
Objective: To describe the characteristics of medication errors in outpatient dispensing pharmacists 
reported in a pharmaco-surveillance system between 2005 and 2013 in Colombia.
Materials and methods: We conducted a descriptive study by reviewing and categorizing medication 
error reports from outpatient pharmacy services to a national medication dispensing company between 
January, 2005 and September, 2013. Variables considered included: process involved (administration, 
dispensing, prescription and transcription), wrong drug, time delay for the report, error type, cause and 
severity. The analysis was conducted in the SPSS® software, version 22.0.
Results: A total of 14,873 medication errors were reviewed, of which 67.2% in fact occurred, 15.5% 
reached the patient and 0.7% caused harm. Administration (OR=93.61, CI 95%: 48.510-180.655, 
p<0.001), dispensing (OR=21.58, CI 95%: 16.139-28.870, p<0.001), transcription errors (OR=5.64; CI 
95%: 3.488-9.142, p<0.001), medicines for sensory organs (OR=2.04, CI 95%: 1.519-2.756, p<0.001), 
anti-infective drugs for systemic use (OR=1.99, CI 95%: 1.574-2.525, p<0.001), confusion generated with 
the name of the drug (OR=1.28, CI 95%: 1.051-1.560, p=0.014), and trouble interpreting prescriptions 
(OR=1.32, CI 95%: 1.037-1.702, p=0.025) increased the risk for error reaching the patient.
Conclusions: It is necessary to develop surveillance systems for medication errors in ambulatory care, 
focusing on the prescription, transcription and dispensation processes. Special strategies are needed 
for the prevention of medication errors related to anti-infective drugs.
Key words: Medication errors, inappropriate prescribing, adverse drug reaction reporting systems, 
pharmaco-surveillance, Colombia. 
doi: http://dx.doi.org/10.7705/biomedica.v36i2.2693
Errores de medicación en pacientes atendidos en servicios ambulatorios de Colombia, 2005-2013
Introducción. Los errores de medicación en la atención ambulatoria se han estudiado poco, a pesar 
de que representan una amenaza importante para la seguridad del paciente.
Objetivo. Describir las características de los errores de medicación en atención ambulatoria reportados 
por un sistema de farmacovigilancia de Colombia entre el 2005 y el 2013.
Materiales y métodos. Se hizo un estudio descriptivo en el cual se recopilaron, revisaron y categorizaron 
los reportes de errores de medicación de pacientes atendidos en un servicio farmacéutico ambulatorio 
a cargo de una empresa nacional de dispensación de medicamentos, entre enero de 2005 y septiembre 
de 2013. Se consideraron variables que involucraban el proceso (administración, dispensación, 
prescripción y transcripción), el medicamento, el tiempo para elaborar el reporte, el tipo de error, su 
causa y su gravedad. El análisis se hizo con el programa SPSS®, versión 22.0.
Resultados. Se recopilaron 14.873 errores de medicación, de los cuales 67,2 % realmente ocurrió, 
15,5 % afectó al paciente y 0,7 % causó daño. Los errores de administración (p<0,001; OR=93,614; 
IC95% 48,510-180,655), de dispensación (p<0,001; OR=21,585; IC95% 16,139-28,870), de transcripción 
(p<0,001; OR=5,647; IC95% 3,488-9,142), los relacionados con medicamentos para los órganos de los 
sentidos (p<0,001; OR=2,046; IC95% 1,519-2,756), y con los medicamentos de uso sistémico contra 
infecciones (p<0,001; OR=1,993; IC95% 1,574-2,525), la confusión en el nombre del fármaco (p=0,014; 
OR=1,281; IC95% 1,051-1,560) y los problemas en la interpretación de las prescripciones (p=0,025; 
OR=1,328; IC95% 1,037-1,702), aumentaron el riesgo de que el error afectara al paciente.
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Discusión. Es necesario establecer sistemas de vigilancia específicos para errores de medicación 
en los servicios ambulatorios, que hagan énfasis en los procesos de prescripción, transcripción y 
dispensación. Se requieren estrategias específicas para la prevención de los errores de medicación 
relacionados con antibióticos.
Palabras clave: errores de medicación, prescripción inadecuada, sistemas de registro de reacción 
adversa a medicamentos, farmacovigilancia, Colombia.
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A medication error is any preventable event that 
may cause or lead to inappropriate medication use 
or patient harm, related to unwise or inadequate 
professional practice from the moment of pre-
scription to medical order fulfillment (1,2). These 
errors include inadequate selection of the drug, 
dose or route of administration, therapy length or 
incorrect selection according to the potential harm 
related to the characteristics or comorbidities of 
the patient (3,4).
There is strong evidence that all medication error 
problems seem to be bigger outside the hospital. 
However, most research has focused on hospitals 
and the lack of evidence about medication errors in 
ambulatory care does not allow for an estimation of 
the incidence and features of such errors that could 
serve as basis for the development of prevention 
strategies (3).
Most studies are limited to a specific population 
or medication error type; in 2003 in the United 
States, four mistakes per 250 prescriptions per 
pharmacy/day occurred in the ambulatory setting 
(1). That same year in México, prescription errors 
accounted for 15.6% and dispensing errors for 
0.4% of all negative outcomes associated with 
medication (NOM) detected in ambulatory patients 
(5). In 2013, in Germany the NOM were found 
in 18.0% of all ambulatory patients and 11.2% of 
all prescriptions, of which 39.0% occurred during 
the prescription process. However, 95.0% of all 
NOM detected could have been solved partially or 
completely during the initial pharmacy visit (6).
Colombian pharmaco-surveillance system only 
covers adverse drug events and, therefore, 
the nation lacks programs and statistics about 
medication errors. In this context, the aim of this 
study was to describe the characteristics of all 
the medication errors in ambulatory pharmacy 
settings reported to a pharmaco-surveillance 
system gathering information from patients of the 
Colombian health system (Sistema General de 
Seguridad Social en Salud, SGSSS) between 2005 
and 2013.
Materials and methods
A descriptive study was carried out to gather 
information on medication errors that occurred 
between January 1st, 2005 and September 12, 2013 
on ambulatory pharmacies owned by the company 
Audifarma, S.A, which dispenses medications 
prescribed by physicians to 6.5 million people 
affiliated to different health care providers. The 
reports were submitted by the health professional 
(physician, pharmacist, nurse) that detected the 
error through an electronic surveillance system and 
then reviewed by a pharmacist, with the support of 
a physician specialized on pharmacoepidemiology 
if needed. The review by the pharmacists is 
linked to the national pharmaco-surveillance pro- 
gramme of Audifarma, S.A., which periodically 
reports results to the (Instituto Nacional de 
Vigilancia de Medicamentios y Alimentos, Invima).
Variables included in the surveillance system were: 
1) date of occurrence and report; 2) time delay 
for the report, 3) place of occurrence (city and 
pharmacy); 4) process involved (administration, 
dispensing, prescription and transcription); 5) 
ordered drug; 6) wrong drug; 7) moment of 
detection; 8) classification by error type and 
severity according to the taxonomy developed by 
the National Coordinating Council for Medication 
Error Reporting and Prevention (NCCMERP) (7) 
(table 1); 9) contact between the error medication 
and the patient, and 10) consumption of the drug by 
the patient. Medicines were grouped by the time of 
reporting, according to the Anatomical Therapeutic 
Chemical (ATC) classification.
Information was gathered into a database in 
Excel 2010 and analyzed using the IBM SPSS® 
Statistics software, version 22.0 for Windows 
(IBM, USA). An exploratory data analysis was 
performed initially, then χ2 tests were used to 
select variables significantly related to the primary 
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outcome (reaching the patient), that were later 
used to create a logistic regression model. A p 
value of <0.05 was considered to be significant. 
The research was reviewed by the Bioethics 
Committee of the Universidad Tecnológica de 
Pereira (Pereira, Colombia), and it was approved 
as “research without risk” following the principles 
of the Helsinki’s Declaration.
Results
At the time of observation, 14,873 medication 
errors were reported in 362 ambulatory pharmacies 
from 71 cities in 21 states of Colombia, most from 
Bogotá (n=8,917; 60.0%), Antioquia (n=1,304; 
8.8%) and Valle del Cauca (n=919; 6.2%). Errors 
were reported on the day of occurrence in 21.0% 
of the cases (n=3,116), and 70.4% (n=10,463) of 
errors were detected between the first and tenth 
day; the median time for detection was four days 
(interquartile range: 12; range: 0-390 days). On 
average, 1.06 errors were notified for every 
10,000 prescriptions.
Errors in category A, B and C comprised 98.9% of 
the total submitted records (n=14,710) (table 1), 
while 67.2% of all the errors reported really occurred 
(n=9,994) (categories B to I), of which 23.0% 
(n=2,299) reached the patient (categories C to I), 
and the medication was used by 64.1% (n=1,475) 
of these patients. Approximately 3.4% (n=79) of 
these cases resulted in harm; in four of the cases 
(5.1%) (categories G to I) the harm was permanent 
and might have contributed or been related to the 
death of two patients (category I). The severity of 
medication errors is shown in table 1.
The most common process in which errors actually 
occurred (categories B to I) was dispensation (55.5%; 
n=5,548), followed by prescription (40.1%; n=4,006), 
transcription (3.6%; n=355) and administration 
(0.9%; n=85). Most errors that reached the patient 
(n=2,113; 91.9%) and that caused harm (n=72; 
91.1%) occurred in the dispensation process. The 
report rate increased through time until 2011, at 
which point it started to decrease (figure 1).
Errors in medication name, concentration, dosage 
form and quantity were the most common. 
Generally, medication errors were detected during 
medical prescription review (37.1%), while almost 
half (48.1%) of those that caused harm were 
detected by the patient, as shown in table 2.
There were 14,826 reports of 630 substances 
(table 3) and 268 therapeutic subgroups; eleven 
of these errors involved multiple medication and 
forty-seven, illegible prescriptions in which drug 
identification was not possible. As shown in figure 2, 
Table 1. Severity of medication errors, Colombia, 2005-2013
Severity of medication errors n %
A. Circumstances or events that have the capacity to cause error 4,879 32.8
B. An error occurred but the error did not reach the patient 7,695 51.7
C. An error occurred that reached the patient, but did not cause patient harm 2,136 14.4
D. An error occurred that reached the patient and required monitoring to confirm that it resulted 
in no harm to the patient and/or required intervention to preclude harm
84   0.6
E. An error occurred that may have contributed to or resulted in temporary harm to the patient 
and required intervention
64   0.4
F. An error occurred that may have contributed to or resulted in temporary harm to the patient 
and required initial or prolonged hospitalization
11   0.1
G. An error occurred that may have contributed to or resulted in permanent patient harm 0     0.00
H. An error occurred that required intervention necessary to sustain life 2     0.01
I.  An error occurred that may have contributed to or resulted in the patient’s death 2     0.01
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Figure 1. Medication errors reports by year of occurrence, 
2005-2013, Colombia
*January to September
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66.8% of the errors were related to five ATC groups: 
C, A, N, R and J. The prescribed drug was different 
than the selected one in 43.3% of medication errors 
(n=6,420), of which 77.5% (n=4,974) were from a 
different subgroup, and 47.7% (n=3,061) were from 
a different ATC group. Finally, 20.3% (n=1,601) of 
the mismatched drugs reached the patient.
Multivariate analysis showed that medication errors 
during the administration, dispensation and tran-
scription processes, sensory organs medications, 
antibacterials for systemic use, wrong medication 
name, and concentration, significantly increased 
the risk for the drug reaching the patient (categories 
B to I). Conversely, being cared for in Bogotá and 
wrong dosage form were found to diminish the risk 
of the error reaching the patient (table 4).
Errors reported in the database were analyzed and 
corrected, if possible, in the moment of detection 
by a pharmacist. Actions to prevent further similar 
errors were also considered and executed.
Discussion
The construction of a national reporting system for 
medication errors covering as many ambulatory 
and medical institutions as possible is the first step 
towards the creation of policies and local actions 
aimed at preventing medication errors. Most work 
around medication errors focuses on prevention 
inside the hospital, but this study shows the 
relevance of including ambulatory pharmacies in 
the strategies for medication errors prevention, as 
they represent a potential risk for patients (1), even 
though most errors reported were mild.
Table 2. General characteristics of medication errors, Colombia, 2005-2013
All errors (A-I)
Reached patients (C-I) 
n=2299
Caused harm  (E-I)
n=79
Type of medication error
Wrong concentration 32.3 38.1 22.0
Improper dose/quantity 26.5 16.9 16.0
Wrong drug 21.2 27.0 48.0
Incomplete formula   3.7   0.9   0.0
Wrong patient   3.6   4.0   2.0
Wrong route   3.5   2.0   2.0
Extra drug   3.4   7.1   4.0
Wrong dosage form   3.2   2.6   4.0
Unreadable formula   2.4   1.2   0.0
Wrong technique     0.01   0.1   2.0
Process where the medication error was detected
Medical prescription review 37.1 32.6   8.9
Dispensation 31.1   3.0   2.5
By the patient 11.3 27.1 48.1
Delivery or posterior   6.4 20.6 12.7
Enlistment   6.2   0.5   0.0
Patient review   5.0   6.2   8.9
Other   2.4   7.2   0.0
Medical follow-up   0.2   1.5   3.8
Dosing   0.2   0.3   0.0
Emergency room visit   0.1   1.0 15.2
Table 3. Most reported drugs in medication errors, Colombia, 2005-2013
All errors (A-I)
(n=14,826)
% Reached patients (C-I) 
(n=2,299)
% Caused harm (E-I) 
(n=79)
%
Paracetamol 3.1 Cefalexin 2.4 Prednisolone 8.3
Metronidazole 3.0 Metronidazole 2.1 Butyl scopolamine 4.2
Losartan 2.7 Dexamethasone and anti-infective agents  1.9 Gemfibrozil 4.2
Levothyroxine sodium 2.7 Dicloxacilin 1.8 Metronidazole 4.2
Enalapril 2.1 Amoxiciline 1.8 Metoclopramide 2.8
Loratadine 2.0 Diphenhydramine 1.8 Insulin (human)  2.8
Amoxiciline 1.9 Nifedipine 1.7 Thiamine (vit. B1)  2.8
Metoprolol 1.7 Levothyroxine sodium 1.6 Enalapril  2.8
Chlorpheniramine 1.7 Ciprofloxacin 1.6 Medroxyprogesterone  2.8
Metoclopramide 1.6 Losartan 1.3 Levothyroxine sodium 2.8
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The characteristics of the drug (wrong concentration, 
dose, quantity and drug) were involved in 80.0% of 
all errors, 82.0% of those that reached the patient 
and 86.0% of those that caused harm, contrary to 
the pharmacopeia report from the United States 
(US), that stated omission errors as the leading 
type, while only a small number of errors related to 
the drug (1,8). Look-alike sound-alike drug names 
have been identified as a clear cause of medication 
errors and the strategies to avoid them include both 
pharmacy practices (e.g., avoid storing drugs by 
alphabetical order and create “flags” in electronic 
dispensing systems) and drug labeling regulations 
to prevent confusions (9,10).
The medication errors found in this study were 
less severe than those reported in the USA, where 
91.3% actually occurred and of those, 64.0% 
reached the patient (against 67.2% and 23.0% in 
Colombia, respectively), while in both cases a low 
number of errors caused damage to the patient 
(3.0% Vs. 0.7%). Further studies are required 
to determine if this difference is explained by 
underreport of serious medication errors or more 
effective functioning of the program, since the 
errors are reported through surveillance and the 
rate of report is unknown. The overall percentage 
of errors reaching the patient (15.5%) could be 
explained by the difference between a hospital and 
an ambulatory environment, where the interaction 
between staff and patient is lower at all stages of 
drug consumption (1). 
Moreover, medication errors that occur in ambu-
latory settings require different systems for vigilance 
and control. Efforts should be aimed at preventing 
errors during the distribution phase, which is the 
last contact between the health care personnel and 
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Figure 2. Medication errors by ATC group in ambulatory settings, Colombia, 2005-2013 
C: Cardiovascular system; A: Alimentary tract and metabolism; N: Nervous system; R: Respiratory system; J: Anti-infective agents 
for systemic use; S: Sensory organs; M: Musculo-skeletal system; H: Systemic hormonal preparations excluding sex hormones 
and insulin; G: Genito-urinary system and sex hormones; P: Antiparasitic products, insecticides and repellents; B: Blood and blood 
forming organs; D: Dermatological medications; L: Antineoplastic and immunomodulating agents; V: Various 
Table 4. Multivariate analysis with variables associated significantly to the occurrence of errors that reach the patient in Colombia 
during 2005-2013
Variables n % p OR CI 95% 
Process 
Administration   64 75.29 <0.001 87.49   48.58-171.72
Dispensation            2,113 38.09 <0.001 20.67   15.4-28.02
Transcription   47 13.24 <0.001   5.51 3.38-9.00
ATC group
Sense organs 203 24.43 <0.001   2.02 1.47-2.78
Anti-infective drugs for systemic use 377 24.15 <0.001   1.98 1.52-2.57
Type
Wrong concentration 614 15.94 0.05   1.29 1.00-1.66
Wrong drug name 435 17.21 0.01   1.43 1.11-1.86
Wrong dosage form 191   8.18 0.01   0.67 0.50-0.90
Occurrence location
Bogotá 724   8.12 <0.001   0.61 0.49-0.75
256
Biomédica 2016;36:251-7Machado-Alba JE, Moncada JC, Moreno-Gutiérrez PA
the patient in outpatient settings, and was linked 
to almost all errors that reached the patient and 
caused harm.
Administration errors comprised only 0.9% of the 
total, significantly less than studies performed 
previously in health institutions in US, Spain, Iran 
and Southeast Asian countries, which reported 
percentages between 15.2% and 88.6% (1,10-13). 
Nevertheless, three quarters of the administration 
errors that occurred reached the patient. These 
types of errors have been generally associated 
with nursing actions (14), and related to factors 
like a heavy workload, lack of knowledge, wrong 
calculations and distractions related to work envi-
ronment in hospitals (13,15), while their occurrence 
in outpatient care may be related to inadequate 
prescription by the physician.
In contrast to our findings, more than half (59.1%) 
of the medication errors that reached the patient 
in a study performed in Danish community phar-
macies were related to the transcription phase. 
These errors were mainly caused by handwritten 
prescriptions, similarities in packages or names, 
“traps” that lead to confusion or misunderstanding 
of prescriptions, lack of effective control (errors 
that are not detected by the pharmacist) and lack 
of concentration caused by interruptions (10). 
Despite this difference, the prevention of errors 
during prescription and transcription phases has a 
significant impact on the incidence of medication 
errors because problems related to handwritten 
medical prescriptions have been identified as 
inducing medication errors (2,16).
Another important strategy for the prevention 
and detection of medication errors are electronic 
prescription systems, that offer the possibility of 
connecting all steps in patient care in addition to 
preventing errors related to handwriting, dosing 
interval, dose, and drug interactions, and decreasing 
errors that happen during transcription; however, 
in many instances access to this device may be 
limited (16,17).
In this study, the main drugs involved in medication 
errors matched the drugs most used for the treatment 
of common illnesses like chronic diseases, pain and 
infections. This is similar to data found in Germany, 
where antibiotics, non-steroidal anti-inflammatory 
drugs (NSAID), β-blocking agents and inhibitors 
of the renin-angiotensin system represent 35.3% 
of NOM detected in ambulatory dispensing. 
Even when these medications have wide security 
profiles, they require special attention due to their 
frequent use (6).
The Agency for Health Research and Quality 
(AHRQ) identified anti-infective agents as the 
pharmaceutical group most associated with drug 
adverse reactions, and different studies have 
shown these drugs to be among the medications 
most frequently involved in hospital and ambulatory 
medication errors (6,18-21). Additionally, in this work 
they increased the risk of reaching the patient. This 
pharmaceutical group requires specific approaches 
that take into consideration the dosage form, 
monitoring and dissemination of clinical practice 
guidelines, electronic prescribing systems and 
surveillance of all processes involved (2,22).
None of the ATC principles stood above the others 
significantly; moreover, the similar frequency of the 
ATC groups C, A, N, R and J was probably related 
to the frequency of use of different groups of 
medications in ambulatory care. On the other hand, 
medicines for sensory organs were involved in a 
small proportion of errors, but they were twice likely 
to reach the patient than other drugs, therefore, the 
dosage form must be evaluated and additional risk 
factors should be identified in order to implement 
corrective and preventive actions.
Three quarters of the medication errors happened 
in the biggest states and in the country’s capital, 
where, despite the fact that pharmacies cover a 
large part of the territory, there is evidence that they 
have stricter monitoring programs and the staff is 
watchful and aware of the importance of notification. 
This may help to explain why having a prescription 
filled in Bogotá was found to be a protective factor 
for the error reaching the patient because of frequent 
reporting of all kinds of errors, while in other cities, 
only more severe errors were reported.
Based on the findings of this study, we can say that 
the most common medication errors in ambulatory 
practice were related to the dispensing and pre-
scription processes, they were of low severity 
and usually did not reach the patient. On the 
other hand, medicines for sensory organs, anti-
infective agents for systemic use, wrong medicine 
name or concentration were all identified as error 
characteristics that increase the risk of the drug 
reaching the patient.
Medication errors included in this paper were limited 
to those submitted on a self-report database, which 
included some of the errors but did not detect the 
totality of the actual errors that occurred. Besides, 
the final consequences in harmed patients and 
corrective measures taken after reviewing the 
error were not always recorded and, therefore, not 
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reported. These results are applicable to groups 
of population with similar socio-demographic 
characteristics and health insurance affiliation.
According to our results, the creation of a database 
that follows NCCMERP standards to gather the 
reports of medication errors occurring in different 
national institutions would improve health staffs’ 
knowledge and awareness about this issue (1), and 
increase error detection. These programs should 
also include the continuous involvement of the 
pharmacist in the entire process of medication use 
and the development of systems for evaluation and 
control of factors that are determinant of severity, 
with emphasis on high-risk operative procedures 
and medicines. Finally, it is necessary to improve 
training and reporting of medication errors, espe-
cially in decentralized settings.
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